Filter
1292
Filtered Results: 1292
Text search:
drug
susceptibility
Featured
Recommendations
158
New Publications
312
Language
Document type
No document type
722
Guidelines
222
Studies & Reports
210
Manuals
57
Strategic & Response Plan
36
Fact sheets
19
Training Material
14
Situation Updates
10
Online Courses
2
Countries / Regions
India
63
Western and Central Europe
44
Ethiopia
32
Eastern Europe
31
Kenya
30
Latin America and the Carribbean
28
South Africa
24
Global
21
Africa
21
Tanzania
19
Nepal
18
Nigeria
18
Zambia
18
Uganda
16
Bangladesh
15
Malawi
14
Philippines
14
Rwanda
12
Ghana
11
Peru
11
Sierra Leone
10
Asia
10
South–East Asia Region
10
Liberia
10
Colombia
9
Zimbabwe
9
Ukraine
8
Mozambique
8
Cambodia
8
Argentina
7
Lesotho
6
Brazil
6
Russia
6
Namibia
6
Myanmar / Burma
6
Eswatini/ Swaziland
6
Germany
5
Western Pacific Region
5
Bolivia
5
Botswana
5
Pakistan
5
Tajikistan
4
El Salvador
4
Cameroon
4
Senegal
4
Venezuela
4
Spain
4
Syria
3
Albania
3
Laos
3
Burkina Faso
3
USA
3
Congo, Democratic Republic of
3
Middle East and North Africa
3
Uruguay
3
Lebanon
3
Vietnam
3
Sudan
3
Thailand
2
Turkey
2
Chile
2
Fiji
2
Afghanistan
2
Morocco
2
Armenia
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
Gabon
2
United Kingdom
2
East and Southern Africa
2
Georgia
2
Angola
2
Bhutan
2
Indonesia
2
Iraq
2
Ecuador
2
North Macedonia
1
Timor Leste/ East Timor
1
Mexico
1
Benin
1
Gambia
1
China
1
Iran
1
Qatar
1
Haiti
1
Ireland
1
West and Central Africa
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Papua New Guinea
1
Nicaragua
1
Sri Lanka
1
Greece
1
Honduras
1
Mali
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
409
Clinical Guidelines
166
Public Health
63
Women & Child Health
27
Pharmacy & Technologies
22
Key Resources
20
Capacity Building
16
Toolboxes
TB
379
AMR
197
HIV
101
COVID-19
49
NTDs
44
Mental Health
40
Rapid Response
39
Planetary Health
25
Pharmacy
20
Refugee
15
Ebola
15
Global Health Education
14
Caregiver
12
NCDs
11
Polio
11
Natural Hazards
8
Cholera
8
Conflict
7
Specific Hazards
6
Disability
4
Zika
3
This document provides guidance on the implementation of the shielding approach in camps and camp-like settings for refugees and internally displaced persons. It is intended for the displaced community itself, humanitarian actors and camp coordination / management authorit...
This document provides guidance on the implementation of the shielding approach in urban areas in LICs and crisis-affected regions. It is intended for the community itself, national and local governance institutions, and humanitarian and development actors operating in the country.
1 June 2020
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidan...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
This publication marks the 25th anniversary of the Beijing Declaration and Platform for Action. It is dedicated to the women leaders and allied community mobilizers who have devoted their lives to advancing the human rights and dignity of all people affected by the HIV epidemic, and to opposing soci...
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overall aim to inform national COVID-19 outbreak respons...
This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight recommendations contained within the World Health ...
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
Zoonotic tuberculosis (TB) is a form of TB in people predominantly caused by the bacterial species, Mycobacterium bovis, which belongs to the M. tuberculosis complex. The implications of zoonotic TB go beyond human health. The organism is host-adapted to cattle, where it is refer...
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control....
With this quick reference guide, providers can easily recognize diseases and side effects related to climate change, implement appropriate management and provide guidance to exposed populations, provide up-to-date information on the relationship between the adverse effects of certain drugs and the w...
Con esta guía de referencia rápida podrán reconocer con facilidad las enfermedades y efectos secundarios relacionados con el cambio climático, administrar los tratamientos adecuados y aconsejar a las poblaciones expuestas, presentar información actualizada sobre la relación entre los efectos s...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
State of Health in the EU Cycle.
With the coronavirus (COVID-19) once again spreading rapidly, and the re-introduction of containment measures to flatten the curve of the epidemic, it is crucial for policymakers to plan effective strategies to re-open their economies to avoid further re-confinement...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of policy recommendation...
Blended Learning Modulef or the Health Extension Programme
In this study session, you will learn about the general features of faeco-oraldiseases: the main types commonly found in Ethiopia, their general symptomsand signs, how to treat mild cases and when to refer patients with severeconditions for...
